FDA Clears Emerging AI's Automated Brain MRI Segmentation Tool

FDA cleared Emerging AI's automated brain MRI segmentation module, the company announced. It automatically segments brain structures on MRI. Performance metrics were not disclosed in the announcement.

• The module provides automated segmentation of brain structures on MRI, potentially reducing manual effort.
• Intended to aid radiologists in neuroimaging workflows; specific clinical accuracy or validation data were not provided in the source.
• Clearance allows commercial distribution in the United States.

Automated summary

RadPigeon summaries are original and for information only. They are not clinical advice.